Which two conditions comprise the high-risk profile for aluminum toxicity in PN patients?

Which two conditions comprise the high-risk profile for aluminum toxicity in PN patients?

• A. Renal failure and iron deficiency anemia
• B. Renal failure and obesity
• C. Iron deficiency anemia and liver disease
• D. Obesity and dehydration

Answer: (A)

Aluminum toxicity risk in parenteral nutrition hinges on two factors: impaired elimination and increased absorption. In renal failure, the body can’t excrete aluminum efficiently, so even small amounts present in PN can accumulate over time. Iron deficiency anemia raises absorption of aluminum because iron deficiency upregulates intestinal transport pathways (such as DMT1) that take up metals; this nonselective boost increases aluminum uptake from PN solutions. Together, reduced clearance and enhanced absorption create the high-risk profile. Other conditions like obesity, dehydration, or liver disease don’t have the same proven impact on aluminum handling in PN.

Aluminum toxicity risk in parenteral nutrition hinges on two factors: impaired elimination and increased absorption. In renal failure, the body can’t excrete aluminum efficiently, so even small amounts present in PN can accumulate over time. Iron deficiency anemia raises absorption of aluminum because iron deficiency upregulates intestinal transport pathways (such as DMT1) that take up metals; this nonselective boost increases aluminum uptake from PN solutions. Together, reduced clearance and enhanced absorption create the high-risk profile. Other conditions like obesity, dehydration, or liver disease don’t have the same proven impact on aluminum handling in PN.